Pegargiminase

Search with Google Search with Bing

Information
Drug Name
Pegargiminase
Description
Entry(CIViC)
1
CIViC
Disease Mutation EL ET ED CS VO TR Pubmed Links
sarcoma ASS1 LOSS ASS1 LOSS D Predictive Supports Sensitivity/Response Somatic 3 27735949 Detail
Annotation
Description Associated Genes Associated Variants Sensitivity Supported Source Links
90% out of 700 sarcoma samples (comprising 45 hist... ASS1 ASS1 LOSS ASS1 LOSS Sensitivity true CIViC Evidence detail
NCT ID Status Phase Summary Start date Completion date
NCT04965714 Withdrawn Phase 2 Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer April 13, 2022 February 10, 2023